Reassurance for HIV-positive women about short-term risk of bone loss

AIDS Treatment News  Nov 05 09

"Short-term rates of bone loss are similar in younger HIV-positive and HIV-negative women, US investigators report in a study published in the online edition of the Journal of Acquired Immune Deficiency Syndromes. "Although HIV-positive women had lower bone mineral density in the lower spine and neck on entry to the study, they had similar rates of bone loss during follow-up. Moreover, HIV treatment was not a risk factor for bone loss. "'Our results provide some reassurance that short-term bone loss is modest in the majority of premenopausal, weight stable HIV+ women', write the investigators. Full story...

Bookmark and Share

Have your say - be the first to comment

Please login to post a comment


Login


More stories from aids treatment news »

Pregnancy, not nevirapine cause of liver toxicities in HIV-positive women

AIDS Treatment News  4 days ago

"Results of US research 'challenge the notion that nevirapine is uniquely associated with hepatotoxicity during pregnancy.

Surviving to die of something else: AIDS is a rare cause of death in old people with HIV

AIDS Treatment News  4 days ago

"A French study of a group of people with HIV aged over 60 has found that over a four-year period, one in seven of the group died – but not a single death was attributable to an AIDS-defining illness.

Early Treatment, Non-AIDS Disease Management Stressed in New European Guidelines

AIDS Treatment News  4 days ago

"Antiretroviral (ARV) therapy is now recommended for certain people living with HIV with CD4 counts between 350 and 500 cells, according to new HIV treatment guidelines released this week by the European AIDS Clinical Society (EACS).

Low Vitamin D Levels in Alpine HIV Study

AIDS Treatment News  4 days ago

"A new study adds to the evidence that vitamin D deficiency is common in people living with HIV. The new data, from an Italian study reported last week at the 12th European AIDS Conference in Cologne, Germany, and summarized by the National AIDS Treatment Advocacy Project (NATAP), underscore the potential importance of testing for and treating low vitamin D levels to thwart the increased risk of bone deterioration and immune system dysfunction in those infected with the virus.

Protease inhibitor monotherapy as a maintenance regimen: are we edging towards acceptance?

AIDS Treatment News  4 days ago

"An entire session at the 12th European AIDS Conference was devoted to trials of different ritonavir-boosted protease inhibitors (PI/r) used as the sole drug in an antiretroviral regimen.

November 23: New deadline to submit ideas for the National AIDS Strategy

AIDS Treatment News  Nov 16 09

"1. Brainstorm ideas and identify specific action steps that address the three National HIV/AIDS Strategy goals to reduce HIV incidence, increase access to care and optimize health outcomes for people living with HIV, and reduce HIV-related health disparities.

Higher Viral Loads Associated With Metabolic Syndrome

AIDS Treatment News  Nov 14 09

"People with higher HIV levels are more likely to have a cluster of symptoms—called metabolic syndrome—associated with cardiovascular disease than people with lower viral loads, according to a study published in the December [2009] issue of the Journal of Acquired Immune Deficiency Syndromes.

HPV Therapeutic Vaccine Works in an Early Trial

AIDS Treatment News  Nov 14 09

"A therapeutic vaccine designed to help the immune system better control human papillomavirus (HPV) was nearly 50 percent effective in eliminating precancerous genital lesions, according to a study published November 5 in The New England Journal of Medicine.

New Paradigms of First-Line HIV Therapy: Determining When (and With What) to Start

AIDS Treatment News  Nov 13 09

"The cohorts alone probably wouldn't be sufficient to drive dramatic changes in clinical practice, but it's coming along with the fact that we have so many antiretroviral treatment options that are currently very well tolerated, with extremely high levels of efficacy, relatively low levels of toxicity and low levels of resistance, and many other options.

Bill Clinton: Health care reform vital to HIV/AIDS patients

AIDS Treatment News  Nov 12 09

"The homeless are three to nine times more likely to have HIV or AIDS than people with stable housing, according to a 2004 study by the Centers for Disease Control and Prevention and the Department of Housing and Urban Development.